Department of Urology, Oxford Radcliffe Hospitals, Oxford, UK.
BJU Int. 2010 Jun;105(12):1663-6. doi: 10.1111/j.1464-410X.2009.09058.x. Epub 2009 Nov 20.
To develop a relational database (Cancer Research Uro-Oncology Database, CRUD) to enable automatic data collection on all urological malignancies within our region, as there is increasing emphasis on good data collection for surgical patients with cancer, and numerous overlapping systems that are amassing data on the same patients.
Links have been established between pathological databases, multidisciplinary team data-collection systems and patient-survival monitoring facilities, providing accurate pathology, treatment and survival data on all of uro-oncology patients. We are also developing individual modules for the oncological surgeons within our unit that are compatible with the British Association of Urological Surgeons (Section of Oncology), and have plans to connect to the Medical and Clinical Oncology data systems in the future.
Pre-existing protocols for fresh tissue, plasma and urine collection have been incorporated within CRUD via a tissue-tracking system, to comply with the Human Tissue Act 2004, and link these samples to accurate clinical, pathological and survival data. Many research and audit projects have already used these data, including the construction of a 274-case tissue microarray for renal cell carcinoma, microRNA hybridization arrays and analysis of 900 nephrectomy cases from the past three decades.
Our work over the past 3 years in Oxford has established numerous links with organizations collecting data on our uro-oncological patients, and we are now able to collect this excellent combined data on all of these patients, in an automated manner.
开发一个关系数据库(癌症研究泌尿肿瘤数据库,CRUD),以便能够自动收集我们地区所有泌尿恶性肿瘤的相关数据。目前,人们越来越重视收集癌症外科患者的高质量数据,并且有许多重叠的系统正在收集同一患者的数据。
病理数据库、多学科团队数据收集系统和患者生存监测设施之间建立了联系,为所有泌尿肿瘤患者提供准确的病理、治疗和生存数据。我们还为我们科室的肿瘤外科医生开发了与英国泌尿外科学会(肿瘤学分会)兼容的单独模块,并计划未来与医学和临床肿瘤学数据系统连接。
通过组织跟踪系统,将新鲜组织、血浆和尿液采集的现有方案纳入了 CRUD,以符合 2004 年人体组织法案,并将这些样本与准确的临床、病理和生存数据联系起来。许多研究和审计项目已经使用了这些数据,包括构建了 274 例肾细胞癌组织微阵列、microRNA 杂交阵列和过去三十年 900 例肾切除术病例的分析。
在过去 3 年在牛津的工作中,我们与收集我们泌尿肿瘤患者数据的组织建立了许多联系,现在我们能够以自动化的方式收集这些患者的所有优秀数据。